Mkts

Precigen, Inc.

NASDAQ: PGEN
$4.73+0.26 (+5.82%)
As of Nov 9, 9:30 AM ET

Key statistics

Day range
4.314.96
52-week range
3.048.98
Today
Open4.48
Previous close4.73
Volume8.81M
Valuation
Market cap2.88B
P/E ratio—
EPS (TTM)-0.52
Income & risk
Dividend / yield—
Beta1.03
Avg volume10.88M
Discussion

PGEN News

Stories mentioning PGEN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue23,2521,341
Cost of Goods Sold
Gross Profit0.000.000.000.00
Operating Expenses
Research & Development5,63810,478
Sales General & Admin21,04912,359
Total Operating Expenses29,24623,937
Operating Income (Loss)(5,994)(22,596)
Interest Income
Interest Expense
Other Expense290.007.00
Pretax Income(7,929)(54,153)(19,814)(23,966)(60,481)
Tax Provision0.000.000.003.000.00(87.00)12.00(1,689)
Net Income (Loss)(7,929)(23,503)(146,344)(26,642)(54,153)(19,727)(23,978)(58,792)
Earnings Per Share (Basic)(0.02)(0.08)(1.06)(0.09)(0.18)(0.07)(0.09)(0.23)
Earnings Per Share (Diluted)(0.02)(0.08)(1.06)(0.09)(0.18)(0.07)(0.09)(0.23)
Weighted Average Shares Outstanding (Basic)354,291312,981307,170296,435293,880267,727275,881252,367
Weighted Average Shares Outstanding (Diluted)354,291312,981307,170296,435293,880267,727275,881252,367

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About PGEN

Precigen, Inc. (NASDAQ: PGEN) is a stock listed on the Nasdaq Stock Market under the ticker symbol PGEN. It last traded at $4.73 (Nov 9, 2026, 9:30 AM ET), up 5.8% on the day. That gives Precigen a market capitalisation of $2.9B.

Over the past 52 weeks PGEN has traded between $3.04 and $8.98.

Revenue for the quarter ended Mar 31, 2026 was $23.3M; a net loss of $7.9M. Revenue was up 1634% from $1.3M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$23.3M-$7.9M-34.1%
Dec 31, 2025—-$23.5M—
Sep 30, 2025—-$146.3M—
Jun 30, 2025—-$26.6M—

From Precigen’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…